Micron’s Valuation Premium Faces a Direct Challenge

For years, Micron Technology has enjoyed a unique status as the sole U.S.-listed provider of DRAM memory chips. This singular position has historically supported a valuation premium for its shares. That competitive advantage may soon be tested. SK Hynix, a critical memory chip supplier to Nvidia, has filed for a U.S. stock listing. This move would, for the first time, offer American investors a direct, publicly-traded alternative.

Robust Fundamentals Amid Shifting Sentiment

The company’s operational performance remains strong. In its fiscal second quarter of 2026, Micron reported revenue of $23.86 billion, nearly triple the figure from the prior-year period. For the following quarter, the company is projecting gross margins of approximately 80%, a level that would surpass even Nvidia’s industry-leading profitability. Furthermore, Micron has initiated volume production of its HBM4 chips, designed for Nvidia’s upcoming Vera Rubin platform, and its entire HBM production capacity for 2026 is already committed under long-term agreements with data center operators and chipmakers.

Positive analyst commentary has also provided support. Shares advanced 3.1% on Monday following a bullish assessment from KeyBanc Capital Markets. The firm’s analysts anticipate DRAM and NAND flash memory prices will climb between 30% and 50% quarter-over-quarter in Q2 2026.

The Looming Threat of Capital Rotation

The structural risk to Micron’s premium stems from SK Hynix’s planned U.S. debut. The listing, which could raise up to $10 billion, would rank among the largest U.S. market introductions by a foreign company. SK Hynix intends to place two to three percent of its total shares, with proceeds earmarked to fund chip fabrication plants in South Korea and the U.S. state of Indiana.

Should investors sell immediately? Or is it worth buying Micron?

Market participants are already weighing the potential for capital flows to shift. “You will see a rotation of fast money out of Micron and into SK Hynix because SK Hynix is currently trading at lower valuations,” stated Rob Li, Managing Partner at New York hedge fund Amont Partners. Both companies trade at roughly four times expected earnings, with Micron’s slight premium largely attributed to its exclusive U.S. listing status until now.

Despite this, some maintain a constructive long-term view of Micron. Morgan Stanley continues to rate the shares as Overweight, characterizing recent price declines as a healthy correction absent a fundamental deterioration. Jung In Yun, CEO of Fibonacci Asset Management Global, also sees Micron holding an edge, arguing the company’s faster earnings growth trajectory will drive superior share performance compared to SK Hynix over time.

Aggressive Investment Carries Inherent Risk

To secure future capacity, Micron has elevated its capital expenditure plan for 2026 to $25 billion, with further increases projected in subsequent years. While this investment secures manufacturing scale, it introduces the risk of margin compression should end-market demand soften more than currently anticipated.

The timing of the competitive shift remains uncertain. SK Hynix has stated its aim to complete the U.S. listing within 2026, but specific details regarding size, structure, and schedule are not yet finalized. For the time being, Micron retains its unique market position—and the associated slice of its valuation premium.